IOZK Article by Prof. Schirrmacher in the German Journal of Oncology on the fundamentals of immunotherapy
An article by Prof. Schirrmacher appears in the German Journal of Oncology. It explains the basics of immunotherapy and uses examples to illustrate which strategies have achieved particularly promising results.
Advances in cancer treatment are urgently needed to increase the effectiveness of treatment. Over the past 20 years, immunotherapy has developed rapidly as a new form of biological treatment. Impressive clinical results with newly approved immunotherapeutic drugs, especially immune checkpoint inhibitors, have further increased the importance of immunotherapy. It is characterized by a higher tumor specificity compared to chemotherapy and radiation therapy."
